WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017179012) NUTRACEUTICAL OR PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME OR OF DISEASES OR DISORDERS RELATED THERETO
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/179012 International Application No.: PCT/IB2017/052151
Publication Date: 19.10.2017 International Filing Date: 13.04.2017
IPC:
A61K 9/00 (2006.01) ,A61K 31/047 (2006.01) ,A61K 31/05 (2006.01) ,A61K 31/519 (2006.01) ,A61K 31/593 (2006.01) ,A61K 33/08 (2006.01) ,A61K 33/32 (2006.01) ,A61P 15/00 (2006.01) ,A61P 43/00 (2006.01)
Applicants: S&R FARMACEUTICI S.P.A.[IT/IT]; Via dei Pioppi n. 2 06083 Bastia Umbra, IT
Inventors: FIORETTI, Bernard; IT
LEONARDI, Lucio; IT
Agent: GRASSO, Vincenzo; IT
Priority Data:
10201600003824313.04.2016IT
Title (EN) NUTRACEUTICAL OR PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME OR OF DISEASES OR DISORDERS RELATED THERETO
(FR) COMPOSITION NUTRACEUTIQUE OU PHARMACEUTIQUE DESTINÉE À ÊTRE UTILISÉE DANS LE TRAITEMENT DU SYNDROME DES OVAIRES POLYKYSTIQUES OU DE MALADIES OU DE TROUBLES ASSOCIÉS À CE DERNIER
Abstract:
(EN) The present invention relates to a pharmaceutical or nutraceutical composition comprising at least one inositol and resveratrol for use in the a) preventive and/or curative treatment in the metabolic disorders related to polycystic ovary syndrome; b) treatment to reduce the symptoms associated with polycystic ovary syndrome such as menstrual cycle alterations and infertility; and/or c) to decrease glucose, triglyceride and BMI levels in subjects with metabolic syndrome.
(FR) La présente invention concerne une composition pharmaceutique ou nutraceutique comprenant au moins de l'inositol et du resvératrol destinée à être utilisée dans a) le traitement préventif et/ou curatif des troubles métaboliques liés au syndrome des ovaires polykystiques; b) un traitement pour réduire les symptômes associés au syndrome des ovaires polykystiques, tels que des altérations du cycle menstruel et l'infertilité; et/ou c) pour diminuer les taux de glucose, de triglycérides et de BMI chez les sujets souffrant d'un syndrome métabolique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: Italian (IT)